These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 21584634

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Prognostic Significance of Concurrent Hypovascular and Hypervascular Nodules in Patients with Hepatocellular Carcinoma.
    Ogasawara S, Chiba T, Motoyama T, Kanogawa N, Saito T, Shinozaki Y, Suzuki E, Ooka Y, Tawada A, Kato H, Okabe S, Kanai F, Yoshikawa M, Yokosuka O.
    PLoS One; 2016; 11(9):e0163119. PubMed ID: 27649084
    [Abstract] [Full Text] [Related]

  • 3. Nonresectable combined hepatocellular carcinoma and cholangiocarcinoma: analysis of the response and prognostic factors after transcatheter arterial chemoembolization.
    Kim JH, Yoon HK, Ko GY, Gwon DI, Jang CS, Song HY, Shin JH, Sung KB.
    Radiology; 2010 Apr; 255(1):270-7. PubMed ID: 20308463
    [Abstract] [Full Text] [Related]

  • 4. Expression of keratin 19 is related to high recurrence of hepatocellular carcinoma after radiofrequency ablation.
    Tsuchiya K, Komuta M, Yasui Y, Tamaki N, Hosokawa T, Ueda K, Kuzuya T, Itakura J, Nakanishi H, Takahashi Y, Kurosaki M, Asahina Y, Enomoto N, Sakamoto M, Izumi N.
    Oncology; 2011 Apr; 80(3-4):278-88. PubMed ID: 21734420
    [Abstract] [Full Text] [Related]

  • 5. [CK19 can be used to predict the early recurrence and prognosis of HBV-related hepatocellular carcinoma patients with low AFP serum concentration after R0 radical hepatectomy].
    Wang ZS, Wu LQ, Yi X, Geng C, Li YJ, Yao RY, Hu WY, Han B.
    Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):753-8. PubMed ID: 23291069
    [Abstract] [Full Text] [Related]

  • 6. CK19 and Glypican 3 Expression Profiling in the Prognostic Indication for Patients with HCC after Surgical Resection.
    Feng J, Zhu R, Chang C, Yu L, Cao F, Zhu G, Chen F, Xia H, Lv F, Zhang S, Sun L.
    PLoS One; 2016 Oct; 11(3):e0151501. PubMed ID: 26977595
    [Abstract] [Full Text] [Related]

  • 7. Tumor response on CT following hypofractionated stereotactic ablative body radiotherapy for small hypervascular hepatocellular carcinoma with cirrhosis.
    Sanuki N, Takeda A, Mizuno T, Oku Y, Eriguchi T, Iwabuchi S, Kunieda E.
    AJR Am J Roentgenol; 2013 Dec; 201(6):W812-20. PubMed ID: 24261388
    [Abstract] [Full Text] [Related]

  • 8. Role of p53 and β-catenin mutations in conjunction with CK19 expression on early tumor recurrence and prognosis of hepatocellular carcinoma.
    Yuan RH, Jeng YM, Hu RH, Lai PL, Lee PH, Cheng CC, Hsu HC.
    J Gastrointest Surg; 2011 Feb; 15(2):321-9. PubMed ID: 21061181
    [Abstract] [Full Text] [Related]

  • 9. Two pathologic types of hepatocellular carcinoma with lymph node metastasis with distinct prognosis on the basis of CK19 expression in tumor.
    Zhuang PY, Zhang JB, Zhu XD, Zhang W, Wu WZ, Tan YS, Hou J, Tang ZY, Qin LX, Sun HC.
    Cancer; 2008 Jun 15; 112(12):2740-8. PubMed ID: 18412155
    [Abstract] [Full Text] [Related]

  • 10. Heterogeneous type 4 enhancement of hepatocellular carcinoma on dynamic CT is associated with tumor recurrence after radiofrequency ablation.
    Kawamura Y, Ikeda K, Seko Y, Hosaka T, Kobayashi M, Saitoh S, Kumada H.
    AJR Am J Roentgenol; 2011 Oct 15; 197(4):W665-73. PubMed ID: 21940538
    [Abstract] [Full Text] [Related]

  • 11. Imaging Features of Gadoxetic Acid-enhanced and Diffusion-weighted MR Imaging for Identifying Cytokeratin 19-positive Hepatocellular Carcinoma: A Retrospective Observational Study.
    Choi SY, Kim SH, Park CK, Min JH, Lee JE, Choi YH, Lee BR.
    Radiology; 2018 Mar 15; 286(3):897-908. PubMed ID: 29166246
    [Abstract] [Full Text] [Related]

  • 12. MRI features of hepatocellular carcinoma expressing progenitor cell markers.
    Jeong HT, Kim MJ, Kim YE, Park YN, Choi GH, Choi JS.
    Liver Int; 2012 Mar 15; 32(3):430-40. PubMed ID: 22097930
    [Abstract] [Full Text] [Related]

  • 13. Hepatocellular carcinoma expressing cholangiocyte phenotype is a novel subtype with highly aggressive behavior.
    Lu XY, Xi T, Lau WY, Dong H, Zhu Z, Shen F, Wu MC, Cong WM.
    Ann Surg Oncol; 2011 Aug 15; 18(8):2210-7. PubMed ID: 21308485
    [Abstract] [Full Text] [Related]

  • 14. Cytokeratin 10 and cytokeratin 19: predictive markers for poor prognosis in hepatocellular carcinoma patients after curative resection.
    Yang XR, Xu Y, Shi GM, Fan J, Zhou J, Ji Y, Sun HC, Qiu SJ, Yu B, Gao Q, He YZ, Qin WZ, Chen RX, Yang GH, Wu B, Lu Q, Wu ZQ, Tang ZY.
    Clin Cancer Res; 2008 Jun 15; 14(12):3850-9. PubMed ID: 18559605
    [Abstract] [Full Text] [Related]

  • 15. The expression of cytokeratin 19 in lymph nodes was a poor prognostic factor for hepatocellular carcinoma after hepatic resection.
    Lee CW, Kuo WL, Yu MC, Chen TC, Tsai CN, Lee WC, Chen MF.
    World J Surg Oncol; 2013 Jun 12; 11(1):136. PubMed ID: 23758804
    [Abstract] [Full Text] [Related]

  • 16. Hepatocellular carcinoma: correlation of CT, angiographic, and histopathologic findings.
    Honda H, Ochiai K, Adachi E, Yasumori K, Hayashi T, Kawashima A, Fukuya T, Gibo M, Matsumata T, Tsuneyoshi M.
    Radiology; 1993 Dec 12; 189(3):857-62. PubMed ID: 8234716
    [Abstract] [Full Text] [Related]

  • 17. Computed tomography follow-up for the detection of hepatocellular carcinoma recurrence after initial radiofrequency ablation: a single-center experience.
    Mikami S, Tateishi R, Akahane M, Asaoka Y, Kondo Y, Goto T, Shiina S, Yoshida H, Koike K.
    J Vasc Interv Radiol; 2012 Oct 12; 23(10):1269-75. PubMed ID: 22999746
    [Abstract] [Full Text] [Related]

  • 18. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL, Sun J, Lai JJ, Jiang Y, Bai LH, Zhang LD.
    World J Gastroenterol; 2015 Jun 07; 21(21):6649-59. PubMed ID: 26074703
    [Abstract] [Full Text] [Related]

  • 19. Combination with CK19 Might Increase the Prognostic Power of Hep Par 1 in Hepatocellular Carcinoma after Curative Resection.
    Jin Y, Liang ZY, Zhou WX, Zhou L.
    J Invest Surg; 2018 Oct 07; 31(5):412-419. PubMed ID: 28758812
    [Abstract] [Full Text] [Related]

  • 20. Expression of bile duct transcription factor HNF1β predicts early tumor recurrence and is a stage-independent prognostic factor in hepatocellular carcinoma.
    Yuan RH, Lai HS, Hsu HC, Lai PL, Jeng YM.
    J Gastrointest Surg; 2014 Oct 07; 18(10):1784-94. PubMed ID: 25052070
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.